2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection Bevacizumab 2 mg/kg, Bevacizumab 4 mg/kg - Chronic Subdural Hematoma | Phase 1 | Completed | The Cooper Health System | 10 | 2024-06-17 | 2026-10-02 |
| Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury Bromocriptine 5 MG, Acetaminophen 650 MG - Subarachnoid Hemorrhage, Subdural Hematoma | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 47 | 2018-11-30 | 2021-06-24 |
Brain Injuries, Traumatic (1) · Cerebral Hemorrhage (1) · Fever (1) · Hematoma, Subdural (1) · Hematoma, Subdural, Chronic (1) · Hyperthermia (1) · Ischemic Stroke (1) · Subarachnoid Hemorrhage (1)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Craniocerebral Trauma (2) · Hemorrhage (2) · Intracranial Hemorrhage, Traumatic (2) · Intracranial Hemorrhages (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Trauma, Nervous System (2) · Vascular Diseases (2) · Wounds and Injuries (2)
Acetaminophen (1) · Bevacizumab (1) · Bromocriptine (1)
The Cooper Health System (1) · University of California, San Francisco (1)
United States (2)
Ajith J Thomas, MD (1) · Jane Khalife, MD (1) · Judy H Ch'ang, MD (1) · Manisha Koneru, MD (1)